Exhibit 32(b)

CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In   connection  with  the  IGENE  Biotechnology,  Inc.  (the  "Company")
Quarterly Report on Form 10-QSB/A for the period ended June 30, 2003,  as
filed with the Securities and Exchange Commission on the date hereof (the
"Report"),  I,  Edward  J.  Weisberger, Chief Financial  Officer  of  the
Company,  certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my
knowledge:

     (1). The  Report  fully  complies  with  the requirements of Section
          13(a)  or  15(d)  of the Securities Exchange Act  of  1934,  as
          amended; and

     (2). The information contained in the Report fairly presents, in all
          material  respects,  the  financial  condition  and  results of
          operations of the Company.


Date: July 27, 2005                By:  /s/EDWARD J. WEISBERGER
                                        _______________________
                                           EDWARD J. WEISBERGER
                                           Chief Financial Officer